🔴 Krystal Biotech is trading 4.15% down today as biotech ETF falls 2.50%

Krystal Biotech is trading at $320.96, down -4.15%, with biotech-sector weakness the clearest available explanation.

• No October 6 company-specific announcement appears on Krystal Biotech’s investor-relations news page; its latest listed release is dated September 3.
• The biotech ETF was down 2.50%, amid reported broad negative sentiment and risk aversion. Major market indexes were higher, making the move appear sector-specific rather than a broad-market selloff.
• No volume data was provided.